Back to Search
Start Over
Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
- Source :
- JGH Open: An Open Access Journal of Gastroenterology and Hepatology, JGH Open, Vol 5, Iss 7, Pp 827-830 (2021)
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
-
Abstract
- Rifaximin (RFX) treatment can attenuate not only hyperammonemia but also Enterococcus faecalis translocation and 10‐7G values, suggesting that RFX treatment may improve intestinal inflammation and result in better overall survival.
- Subjects :
- medicine.medical_specialty
liver cirrhosis
hepatic encephalopathy
Chromosomal translocation
RC799-869
Gastroenterology
Enterococcus faecalis
chemistry.chemical_compound
Intestinal inflammation
Internal medicine
intestinal inflammation
medicine
Overall survival
Hepatic encephalopathy
Hepatology
biology
business.industry
Brief Report
Hyperammonemia
Diseases of the digestive system. Gastroenterology
medicine.disease
biology.organism_classification
Rifaximin
rifaximin
chemistry
Brief Reports
business
Subjects
Details
- ISSN :
- 23979070
- Volume :
- 5
- Database :
- OpenAIRE
- Journal :
- JGH Open
- Accession number :
- edsair.doi.dedup.....e44f22a2c626d12a06b31344e5d2eb78